Do you have a winning commercialisation strategy?
The 8-week Catalyser programme helps therapeutics/techbio companies refine their commercialization strategy through a journey involving 12 meso-economic vectors as described by the Triple Chasm model. At the end of the 14 sessions (3 in-person and 11 videocalls) each company gains:
Each session is focused on one of the 12 Triple Chasm vectors and includes:
The SBC Catalyser programme provides:
The programme includes:
Read our Economic Impact Assessment report for more information.
Spaces are limited to 10 companies per cohort. Contact Marco to get more information on our next programme in spring 2024.Contact Marco